Study to Evaluate the Effects of Food Ingestion on the Pharmacokinetics of CHF 5074 in Healthy Young Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions

Alzheimer's Disease

Interventions

DRUG

CHF 5074

Drug is administered to subject in a fasting state

DRUG

CHF 5974

Drug is administered to subject after consumption of a high fat, high calorie meal

Trial Locations (1)

Iberica Clinical Research Center, Eatontown